Skip to main content

Niagen Bioscience, Inc.

NAGE
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0001386570

No open-market purchases or sales by Niagen Bioscience, Inc. insiders were filed in the last 90 days; 139 institutions reported holding it in 13F filings for Q2 2026, worth $102.1M in total; no superinvestor holds it.

Superinvestors holding NAGE, Q2 2026

See all superinvestors

No superinvestor reported holding NAGE in Q2 2026.